palb2 (Cell Signaling Technology Inc)
Structured Review
Palb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/palb2/pm41554690-388-42-35
Average 86 stars, based on 1 article reviews
Images
Related Articles
Western Blot:Article Title: DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition. Article Snippet: .. Cell lysates were collected and analyzed using Western blot with antibodies against ATM (Cell Signaling, D2E2), BARD1 (Santa Cruz, E 11), BRCA1 (Cell Signaling, ABX9F), BRCA2 (Cell Signaling, D9S6V), Article Title: Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions Article Snippet: The percentage of phospho-H2AX-positive cells was quantified using Attune Nxt Flow cytometer (ThermoFisher Scientific) The remaining cells were cultured for additional 21 h (total 24 h) and then counted by Trypan blue exclusion assay (Sigma Aldrich) to evaluate the cell viability. .. Immunoblotting analyses were performed using Mini-Protean TGX stain-free precast gels, blotted to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) and incubated the following antibodies: pATR Ser428 (#2853); pATM Ser1981 (#5883); pCHK2 Thr68 (#2661); pCHK1 Ser345 (#2348); pWEE1 Ser642 (#4910); ATM (#2873); ATR (#13934); CHK1 (#37010); CHK2 (#2662); WEE1 (#13,084); BRCA1 (#9010); BRCA2 (#10741); Staining:Article Title: Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions Article Snippet: The percentage of phospho-H2AX-positive cells was quantified using Attune Nxt Flow cytometer (ThermoFisher Scientific) The remaining cells were cultured for additional 21 h (total 24 h) and then counted by Trypan blue exclusion assay (Sigma Aldrich) to evaluate the cell viability. .. Immunoblotting analyses were performed using Mini-Protean TGX stain-free precast gels, blotted to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) and incubated the following antibodies: pATR Ser428 (#2853); pATM Ser1981 (#5883); pCHK2 Thr68 (#2661); pCHK1 Ser345 (#2348); pWEE1 Ser642 (#4910); ATM (#2873); ATR (#13934); CHK1 (#37010); CHK2 (#2662); WEE1 (#13,084); BRCA1 (#9010); BRCA2 (#10741); Incubation:Article Title: Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions Article Snippet: The percentage of phospho-H2AX-positive cells was quantified using Attune Nxt Flow cytometer (ThermoFisher Scientific) The remaining cells were cultured for additional 21 h (total 24 h) and then counted by Trypan blue exclusion assay (Sigma Aldrich) to evaluate the cell viability. .. Immunoblotting analyses were performed using Mini-Protean TGX stain-free precast gels, blotted to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) and incubated the following antibodies: pATR Ser428 (#2853); pATM Ser1981 (#5883); pCHK2 Thr68 (#2661); pCHK1 Ser345 (#2348); pWEE1 Ser642 (#4910); ATM (#2873); ATR (#13934); CHK1 (#37010); CHK2 (#2662); WEE1 (#13,084); BRCA1 (#9010); BRCA2 (#10741); other:Article Title: DNA Damage Response Deficiency Enhances Neuroblastoma Progression and Sensitivity to Combination PARP and ATR Inhibition Article Snippet: AlamarBlue reagent (Invitrogen) was added for 16-18 hours, and fluorescence was assessed using a microplate reader (Spectra MAX Gemini EM, Molecular Devices) with a l540 excitation/l590 emission filter. Article Title: KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer. Article Snippet: Cell culture media and other reagents were from Invitrogen, Gibco, and Fisher Scientific. Construct:Article Title: Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk. Article Snippet: .. The authors thank Jos Jonkers and Peter Bouwman for providing the pTT5-Puro (RMCE acceptor cassette), pRNA-251-MCS-RMCE (RMCE exchange vector) and pCMV-Red-I-SceI constructs, Maria Jasin and Francis Stewart for sharing the DR-GFP reporter and FlpO constructs, Cell Signaling for providing antibodies directed against |

